SULJE VALIKKO

avaa valikko

James W. Janetka | Akateeminen Kirjakauppa

EXTRACELLULAR TARGETING OF CELL SIGNALING IN CANCER - STRATEGIES DIRECTED AT MET AND RON RECEPTOR TYROSINE KINASE PATHWAYS

Extracellular Targeting of Cell Signaling in Cancer - Strategies Directed at MET and RON Receptor Tyrosine Kinase Pathways
James W. Janetka; Roseann M. Benson
John Wiley & Sons Inc (2018)
Saatavuus: Tilaustuote
Kovakantinen kirja
168,30
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
Extracellular Targeting of Cell Signaling in Cancer - Strategies Directed at MET and RON Receptor Tyrosine Kinase Pathways
168,30 €
John Wiley & Sons Inc
Sivumäärä: 488 sivua
Asu: Kovakantinen kirja
Julkaisuvuosi: 2018, 20.07.2018 (lisätietoa)
Kieli: Englanti
International experts present innovative therapeutic strategies to treat cancer patients and prevent disease progression

Extracellular Targeting of Cell Signaling in Cancer highlights innovative therapeutic strategies to treat cancer metastasis and prevent tumor progression. Currently, there are no drugs available to treat or prevent metastatic cancer other than non-selective, toxic chemotherapy.  With contributions from an international panel of experts in the field, the book integrates diverse aspects of biochemistry, molecular biology, protein engineering, proteomics, cell biology, pharmacology, biophysics, structural biology, medicinal chemistry and drug development.

A large class of proteins called kinases are enzymes required by cancer cells to grow, proliferate, and survive apoptosis (death) by the immune system. Two important kinases are MET and RON which are receptor tyrosine kinases (RTKs) that initiate cell signaling pathways outside the cell surface in response to extracellular ligands (growth factors.) Both kinases are oncogenes which are required by cancer cells to migrate away from the primary tumor, invade surrounding tissue and metastasize. MET and RON reside on both cancer cells and the support cells surrounding the tumor, called the microenvironment. MET and RON are activated by their particular ligands, the growth factors HGF and MSP, respectively. Blocking MET and RON kinase activation and downstream signaling is a promising therapeutic strategy for preventing tumor progression and metastasis. Written for cancer physicians and biologists as well as drug discovery and development teams in both industry and academia, this is the first book of its kind which explores novel approaches to inhibit MET and RON kinases other than traditional small molecule kinase inhibitors. These new strategies target key tumorigenic processes on the outside of the cell, such as growth factor activation by proteases. These unique strategies have promising potential as an improved alternative to kinase inhibitors, chemotherapy, or radiation treatment. 

Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
LISÄÄ OSTOSKORIIN
Tilaustuote | Arvioimme, että tuote lähetetään meiltä noin 14-17 arkipäivässä
Myymäläsaatavuus
Helsinki
Tapiola
Turku
Tampere
Extracellular Targeting of Cell Signaling in Cancer - Strategies Directed at MET and RON Receptor Tyrosine Kinase Pathwayszoom
Näytä kaikki tuotetiedot
ISBN:
9781119300182
Sisäänkirjautuminen
Kirjaudu sisään
Rekisteröityminen
Oma tili
Omat tiedot
Omat tilaukset
Omat laskut
Lisätietoja
Asiakaspalvelu
Tietoa verkkokaupasta
Toimitusehdot
Tietosuojaseloste